Suppr超能文献

运动神经元病的诊断及时性:一项基于人群的研究。

Timeliness of diagnosis in motor neurone disease: a population-based study.

作者信息

Donaghy Colette, Dick Alison, Hardiman Orla, Patterson Victor

机构信息

Department of Neurology, Royal Victoria Hospital, Belfast BT12 6BA, UK.

出版信息

Ulster Med J. 2008 Jan;77(1):18-21.

Abstract

Following the observation from our experience with the Northern Ireland Motor Neurone Disease (MND) register that excessive delays appeared to exist in the diagnosis of patients with MND, we performed a population-based study of the length and factors involved in the diagnostic process. In 73 patients we found that the median time to diagnosis from symptom onset was 15.6 months, being shorter in bulbar onset patients and longer in females or those presenting with nonspecific gait disturbance. We divided this interval into three time periods--symptom onset to first medical contact, first medical contact to neurology referral and neurology referral to diagnosis. The time period from first medical contact to neurology referral was the longest of the three periods studied indicating that appropriate timely referral of patients to neurologists was responsible for the greatest delay in making a diagnosis of MND. We propose that improving the accessibility of neurological services could potentially reduce the time to diagnosis by at least three months.

摘要

根据我们在北爱尔兰运动神经元病(MND)登记处的经验观察,发现MND患者的诊断存在过度延迟,我们对诊断过程的时长及相关因素进行了一项基于人群的研究。在73例患者中,我们发现从症状出现到诊断的中位时间为15.6个月,延髓起病的患者时间较短,女性或出现非特异性步态障碍的患者时间较长。我们将这个间隔分为三个时间段——症状出现到首次就医、首次就医到转介至神经科以及转介至神经科到诊断。研究的三个时间段中,从首次就医到转介至神经科的时间段最长,这表明患者及时转诊至神经科医生是导致MND诊断延迟时间最长的原因。我们建议,改善神经科服务的可及性可能会使诊断时间至少缩短三个月。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/2397016/45f92523d699/umj7701-018-f1.jpg

相似文献

2
Specialist referrals and diagnostic delays in motor neurone disease: Mapping patients' journey through hoops and hurdles in healthcare.
Clin Med (Lond). 2024 Jul;24(4):100228. doi: 10.1016/j.clinme.2024.100228. Epub 2024 Jul 14.
4
GPs have key role in managing motor neurone disease.
Practitioner. 2011 Sep;255(1743):19-22, 2.
5
Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019.
Eur J Neurol. 2022 Mar;29(3):707-714. doi: 10.1111/ene.15172. Epub 2021 Nov 19.
6
Mimics and chameleons in motor neurone disease.
Pract Neurol. 2013 Jun;13(3):153-64. doi: 10.1136/practneurol-2013-000557. Epub 2013 Apr 24.
7
When months matter; modelling the impact of the COVID-19 pandemic on the diagnostic pathway of Motor Neurone Disease (MND).
PLoS One. 2023 Jan 27;18(1):e0259487. doi: 10.1371/journal.pone.0259487. eCollection 2023.
9
Finger extension weakness and downbeat nystagmus motor neurone disease (FEWDON-MND).
Pract Neurol. 2019 Oct;19(5):424-426. doi: 10.1136/practneurol-2018-002188. Epub 2019 Apr 24.
10
Palliative care for patients with motor neurone disease and their bereaved carers: a qualitative study.
BMC Palliat Care. 2019 Apr 26;18(1):39. doi: 10.1186/s12904-019-0423-8.

引用本文的文献

1
Banking on My Voice: Life with Motor Neurone Disease.
Healthcare (Basel). 2025 Jul 21;13(14):1770. doi: 10.3390/healthcare13141770.
3
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective.
Brain Commun. 2021 Oct 23;3(4):fcab242. doi: 10.1093/braincomms/fcab242. eCollection 2021.
5
Early Referral to an ALS Center Reduces Several Months the Diagnostic Delay: A Multicenter-Based Study.
Front Neurol. 2020 Dec 18;11:604922. doi: 10.3389/fneur.2020.604922. eCollection 2020.
6
Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners.
Neurol Res Int. 2020 May 11;2020:1473981. doi: 10.1155/2020/1473981. eCollection 2020.
7
8
Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?
Neurotox Res. 2016 Feb;29(2):201-7. doi: 10.1007/s12640-015-9573-5. Epub 2015 Nov 12.
9
Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.
NeuroRehabilitation. 2015;37(1):53-68. doi: 10.3233/NRE-151240.
10
Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS).
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):453-6. doi: 10.3109/21678421.2014.903974. Epub 2014 Jul 1.

本文引用的文献

1
Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.
J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):30-2. doi: 10.1136/jnnp.2007.117788. Epub 2007 Jul 18.
2
Email triage of new neurological outpatient referrals from general practice.
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):617-20. doi: 10.1136/jnnp.2003.024489.
4
Diagnostic delay in amyotrophic lateral sclerosis: what scope for improvement?
J Neurol Sci. 2000 Nov 1;180(1-2):76-81. doi: 10.1016/s0022-510x(00)00418-4.
6
Motor neurone disease in South Estonia. Diagnosis and incidence rate.
Acta Neurol Scand. 1998 Jul;98(1):22-8. doi: 10.1111/j.1600-0404.1998.tb07373.x.
8
The amyotrophic lateral sclerosis (ALS) patient perspective on misdiagnosis and its repercussions.
J Neurol Sci. 1996 Aug;139 Suppl:110-6. doi: 10.1016/0022-510x(96)00088-3.
9
Communicating the diagnosis of motor neurone disease.
Palliat Med. 1996 Jan;10(1):23-34. doi: 10.1177/026921639601000105.
10
Amyotrophic lateral sclerosis in Sardinia, Italy: an epidemiologic study.
Acta Neurol Scand. 1993 Jun;87(6):446-54. doi: 10.1111/j.1600-0404.1993.tb04134.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验